Year archive

Arctic Bioscience — 2023 filings

All 90 regulatory filings released by Arctic Bioscience (ABS) in 2023, sourced directly from the official regulator.

90 Filings

2023 Period

2023 filings (90)

Filing	Released	Lang
Finansiell kalender Report Publication Announcement	2023-12-15	Norwegian
Financial calendar Report Publication Announcement	2023-12-15	English
Arctic Bioscience - More than 75% recruited in the phase IIb HeROPA clinical trial Regulatory Filings	2023-12-01	English
Arctic Bioscience - Over 75% rekruttert til den kliniske fase IIb HeROPA-studien Regulatory Filings	2023-12-01	Norwegian
Arctic Bioscience - Q3 2023 Operational update - More than 50% recruited in the phase IIb HeROPA clinical trial Earnings Release Q3 2023	2023-11-02	English
Arctic Bioscience - 3. kv. 2023 oppdatering - Over 50% rekruttert til den kliniske fase IIb HeROPA-studien Earnings Release Q3 2023	2023-11-02	Norwegian
Arctic Bioscience - HeROPA study recruitment progressing well and strong nutra revenue growth Investor Presentation	2023-08-29	English
Arctic Bioscience - Rekruttering til HeROPA-studien går godt og sterk nutra inntektsvekst Investor Presentation	2023-08-29	English
Arctic Bioscience - HeROPA study recruitment progressing well and strong nutra revenue growth Interim / Quarterly Report H1 2023	2023-08-29	English
Arctic Bioscience - Rekruttering til HeROPA-studien går godt og sterk nutra inntektsvekst Interim / Quarterly Report H1 2023	2023-08-29	English
Arctic Bioscience - HeROPA study recruitment progressing well and strong nutra revenue growth Earnings Release H1 2023	2023-08-29	English
Arctic Bioscience - Rekruttering til HeROPA-studien går godt og sterk nutra inntektsvekst Earnings Release H1 2023	2023-08-29	Norwegian
Arctic Bioscience - Invitation to presentation of half year 2023 results Report Publication Announcement	2023-08-22	English
Arctic Bioscience - Invitasjon til presentasjon av halvårsresultat for 2023 Report Publication Announcement	2023-08-22	Norwegian
Arctic Bioscience - Credit facility of NOK 30 mill. established Capital/Financing Update	2023-07-07	English
Arctic Bioscience - Registrert aksjekapitalforhøyelse Capital/Financing Update	2023-05-08	Norwegian
Arctic Bioscience - Share capital increase registered Share Issue/Capital Change	2023-05-08	English
Arctic Bioscience - Q1 2023 Operational update - HeROPA clinical trial approved in all 5 countries and ongoing Regulatory Filings	2023-05-08	English
Arctic Bioscience - 1.kv. 2023 oppdatering - HeROPA-studien godkjent i alle fem land og er pågående Interim / Quarterly Report Q1 2023	2023-05-08	Norwegian
Arctic Bioscience - Meldepliktig handel Director's Dealing	2023-04-24	English
Arctic Bioscience - Mandatory notification of trade Director's Dealing	2023-04-24	English
Arctic Bioscience - Meldepliktig handel Share Issue/Capital Change	2023-04-24	Norwegian
Arctic Bioscience - Mandatory notification of trade Director's Dealing	2023-04-24	English
Arctic Bioscience - Approval of share capital increase Share Issue/Capital Change	2023-04-21	English
Arctic Bioscience - Godkjennelse av kapitaløkning Capital/Financing Update	2023-04-21	Norwegian
Arctic Bioscience - Referat fra ordinær generalforsamling AGM Information	2023-04-21	Norwegian
Arctic Bioscience - Minutes of the Annual General Meeting AGM Information	2023-04-21	English
Arctic Bioscience - Referat fra ordinær generalforsamling AGM Information	2023-04-21	Norwegian
Arctic Bioscience - Minutes of the Annual General Meeting AGM Information	2023-04-21	English
Arctic Bioscience - Innkalling til ordinær generalforsamling 21. april 2023 AGM Information	2023-04-14	English
Arctic Bioscience - Innkalling til ordinær generalforsamling 21. april 2023 AGM Information	2023-04-14	Norwegian
Arctic Bioscience - Notice of Annual General Meeting on 21 April 2023 AGM Information	2023-04-14	English
Arctic Bioscience - Notice of Annual General Meeting on 21 April 2023 AGM Information	2023-04-14	English
Arctic Bioscience - Årsrapport 2022 Annual Report FY 2022	2023-03-29	English
Arctic Bioscience - Årsrapport 2022 Report Publication Announcement	2023-03-29	Norwegian
Arctic Bioscience - Annual report 2022 Annual Report FY 2022	2023-03-29	English
Arctic Bioscience - Annual report 2022 Report Publication Announcement	2023-03-29	English
Arctic Bioscience - Invitation to presentation of full year 2022 results Report Publication Announcement	2023-03-23	English
Arctic Bioscience - Invitiasjon til presentasjon av årsresultatet for 2022 Report Publication Announcement	2023-03-23	Norwegian
Arctic Bioscience - Share capital increase registered Share Issue/Capital Change	2023-03-17	English
Arctic Bioscience - Registrert aksjekapitalforhøyelse Share Issue/Capital Change	2023-03-17	Norwegian
Arctic Bioscience - Forlengelse av aksjeopsjoner til medlemmer av ledergruppen Director's Dealing	2023-03-14	English
Arctic Bioscience - Extension of share options to members of management group Director's Dealing	2023-03-14	English
Arctic Bioscience - Forlengelse av aksjeopsjoner til medlemmer av ledergruppen Remuneration Information	2023-03-14	Norwegian
Arctic Bioscience - Extension of share options to members of management group Remuneration Information	2023-03-14	English
Arctic Bioscience - The HeROPA phase IIb clinical trial approved in Norway, Finland, Germany and Poland Regulatory Filings	2023-03-07	English
Arctic Bioscience - Kliniske fase IIb studie, (HeROPA-studien), godkjent for start i Norge, Finland, Tyskland og Polen Regulatory Filings	2023-03-07	Norwegian
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til utøvelse av aksjeopsjoner AGM Information	2023-03-07	Norwegian
Arctic Bioscience - Board approval of share capital increase related to share option exercise AGM Information	2023-03-07	English
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til utøvelse av aksjeopsjoner Share Issue/Capital Change	2023-03-07	Norwegian
Arctic Bioscience - Board approval of share capital increase related to share option exercise Share Issue/Capital Change	2023-03-07	English
Arctic Bioscience - Exercise of share options and issuance of shares Director's Dealing	2023-02-27	English
Arctic Bioscience - Utøvelse av aksjeopsjon og utstedelser av aksjer Director's Dealing	2023-02-27	English
Arctic Bioscience - Exercise of share options and issuance of shares Share Issue/Capital Change	2023-02-27	English
Arctic Bioscience - Utøvelse av aksjeopsjon og utstedelser av aksjer Director's Dealing	2023-02-27	Norwegian
Arctic Bioscience - Meldepliktig handel Director's Dealing	2023-02-23	Norwegian
Arctic Bioscience - Mandatory notification of trade Director's Dealing	2023-02-23	English
Arctic Bioscience - Meldepliktig handel Director's Dealing	2023-02-23	Norwegian
Arctic Bioscience - Mandatory notification of trade Director's Dealing	2023-02-23	English
Arctic Bioscience - Mandatory notification of trade Director's Dealing	2023-02-22	English
Arctic Bioscience - Meldepliktig handel Director's Dealing	2023-02-22	English
Arctic Bioscience - Mandatory notification of trade Director's Dealing	2023-02-22	English
Arctic Bioscience - Meldepliktig handel Director's Dealing	2023-02-22	Norwegian
Arctic Bioscience - Mandatory notification of trade Director's Dealing	2023-02-16	English
Arctic Bioscience - Meldepliktig handel Director's Dealing	2023-02-16	Norwegian
Arctic Bioscience - Mandatory notification of trade Director's Dealing	2023-02-16	English
Arctic Bioscience - Meldepliktig handel Director's Dealing	2023-02-16	Norwegian
Arctic Bioscience - Meldepliktig handel Director's Dealing	2023-02-14	English
Arctic Bioscience - Mandatory notification of trade Director's Dealing	2023-02-14	English
Arctic Bioscience - Meldepliktig handel Director's Dealing	2023-02-14	Norwegian
Arctic Bioscience - Mandatory notification of trade Director's Dealing	2023-02-14	English
Arctic Bioscience - Account for agreement Regulatory Filings	2023-02-13	English
Arctic Bioscience - Redegjørelse for avtale Regulatory Filings	2023-02-13	Norwegian
Arctic Bioscience - Account for agreement Legal Proceedings Report	2023-02-13	English
Arctic Bioscience - Redegjørelse for avtale Regulatory Filings	2023-02-13	Norwegian
Arctic Bioscience - Mandatory notification of trade Director's Dealing	2023-02-13	English
Arctic Bioscience - Meldepliktig handel Director's Dealing	2023-02-13	English
Arctic Bioscience - Mandatory notification of trade Director's Dealing	2023-02-13	English
Arctic Bioscience - Meldepliktig handel Director's Dealing	2023-02-13	Norwegian
Arctic Bioscience - Meldepliktig handel Director's Dealing	2023-02-13	English
Arctic Bioscience - Mandatory notification of trade Director's Dealing	2023-02-13	English
Arctic Bioscience - Meldepliktig handel Director's Dealing	2023-02-13	Norwegian
Arctic Bioscience - Mandatory notification of trade Director's Dealing	2023-02-13	English
Arctic Bioscience - Entering micro algae space Capital/Financing Update	2023-02-13	English
Arctic Bioscience - Etablerer seg innenfor mikroalge-segmentet Regulatory Filings	2023-02-13	Norwegian
Arctic Bioscience - Q4 2022 Operational update - Key pharma milestones achieved and significant growth in revenues Earnings Release Q4 2022	2023-02-09	English
Arctic Bioscience - 4.kv. 2022 oppdatering - Viktige farma-milepæler nådd og sterk omsetningsvekst Earnings Release Q4 2022	2023-02-09	Norwegian
Arctic Bioscience - First patient included in HRO350 Phase IIb clinical trial in the UK Regulatory Filings	2023-02-01	English
Arctic Bioscience - Første pasient inkludert i HRO350 fase IIb klinisk studie i UK Regulatory Filings	2023-02-01	Norwegian
Arctic Bioscience - Clinical Trial Application for HRO350 Phase IIb approved in the UK Regulatory Filings	2023-01-12	English